Lv12
40 积分 2022-08-22 加入
Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer
2小时前
待确认
A new BRAF inhibitor breaks resistance barriers
1天前
已完结
Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase 3 KEYNOTE-006 study
21天前
已完结
2型神经纤维瘤病神经系统肿瘤多学科协作诊疗策略中国专家共识
28天前
已完结
Adjustment for Imbalances in Baseline Characteristics in the MAGNITUDE Phase 3 Study Confirms the Clinical Benefit of Niraparib in Combination with Abiraterone Acetate Plus Prednisone in Patients with Metastatic Prostate Cancer
29天前
已完结
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis
1个月前
已完结
The pancreatic cancer genome revisited
1个月前
已完结
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer
2个月前
已完结
Primary mediastinal germ cell tumors
3个月前
已完结
皖公网安备34019202002308
